Press releases

1 2 3 29

BD Unveils New Solution for High Throughput Molecular Diagnostic Testing

Jun 18, 2019

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the CE-IVDD certification of the BD COR System in Europe.

BD Announces New Leadership for BD Biosciences

Jun 17, 2019

BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the appointment of Puneet Sarin to worldwide president, BD Biosciences, effective today.

New Report Sheds Light on Health Care’s ‘Hidden’ Epidemic – Hospital Drug Diversion – and its Role in the Opioid Crisis

Jun 4, 2019

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today released a new report based on an independent national survey that examines drug diversion in U.S. hospitals, an underreported contributor to the opioid epidemic.

BD Announces Results for 2019 Second Fiscal Quarter; Updates Fiscal 2019 Guidance

May 9, 2019

BD Announces Results for 2019 Second Fiscal Quarter; Updates Fiscal 2019 Guidance

BD Receives FDA Approval for Fully Sterile Chlorhexidine Gluconate Antiseptic Skin Preparation

Apr 30, 2019

BD Receives FDA Approval for Fully Sterile Chlorhexidine Gluconate Antiseptic Skin Preparation

BD Unveils Platelet Quality Control Media to Help Reduce the Incidence of Sepsis in Patients Requiring Platelet Transfusion

Apr 8, 2019

BD Unveils Platelet Quality Control Media to Help Reduce the Incidence of Sepsis in Patients Requiring Platelet Transfusion

BD Launches New Automated Flow Cytometry Sample Preparation Instrument with CE-IVD Certification

Mar 26, 2019

BD Launches New Automated Flow Cytometry Sample Preparation Instrument with CE-IVD Certification

BD Statement on Paclitaxel-Coated Devices

Mar 21, 2019

BD Statement on Paclitaxel-Coated Devices

BD Receives U.S. FDA Approval for First Venous Stent to Treat Iliofemoral Venous Occlusive Disease

Mar 14, 2019

BD Receives U.S. FDA Approval for First Venous Stent to Treat Iliofemoral Venous Occlusive Disease

BD Advances Technology to Create Endovascular AV Fistulas for Chronic Kidney Disease Patients Who Require Hemodialysis

Feb 13, 2019

BD WavelinQ 4F EndoAVF System Receives 510(k) Clearance from U.S. Food and Drug Administration

1 2 3 29

This site uses cookies. If you click accept cookies then all cookies will be written. Please review our cookies policy and configure your cookies for your experience.